SULFAMETHOXAZOLE AND TRIMETHOPRIM

SULFAMETHOXAZOLE AND TRIMETHOPRIM was reported 85163 times

SULFAMETHOXAZOLE AND TRIMETHOPRIM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 169 0.5578
1 HEART FAILURE WITH PRESERVED EJECTION FRACTION 68 0.2313
2 PULMONARY VASCULITIS 109 0.2026
3 C-REACTIVE PROTEIN 168 0.1812
4 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 96 0.1711
5 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1024 0.1575
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 311 0.1553
7 MUSCLE INJURY 1214 0.1464
8 X-RAY ABNORMAL 255 0.1425
9 DUODENAL ULCER PERFORATION 1029 0.1382
10 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 284 0.1369
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 90 0.1347
12 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 98 0.1337
13 FOLLICULITIS 1398 0.1332
14 SWOLLEN JOINT COUNT INCREASED 401 0.1256
15 SPIROMETRY ABNORMAL 75 0.1254
16 MITE ALLERGY 82 0.1252
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 890 0.1241
18 FEBRILE BONE MARROW APLASIA 493 0.1159
19 DISLOCATION OF VERTEBRA 264 0.1156
20 FACET JOINT SYNDROME 371 0.1138
21 FEMALE GENITAL TRACT FISTULA 191 0.1118
22 RHEUMATIC FEVER 494 0.1107
23 MYCOTIC ALLERGY 92 0.1076
24 HELICOBACTER INFECTION 1040 0.1011
25 LUPUS VULGARIS 126 0.1000
26 IMMUNE RECONSTITUTION SYNDROME 129 0.0999
27 HYPOFIBRINOGENAEMIA 93 0.0938
28 RHEUMATOID FACTOR POSITIVE 506 0.0875
29 HAND DEFORMITY 1074 0.0818
30 APLASIA 154 0.0786
31 BLOOD PRESSURE DIASTOLIC ABNORMAL 196 0.0770
32 PEMPHIGUS 963 0.0769
33 RADICULOPATHY 202 0.0766
34 DUST ALLERGY 73 0.0744
35 NEURITIS 113 0.0731
36 C-REACTIVE PROTEIN ABNORMAL 449 0.0699
37 PROCTITIS 192 0.0685
38 IRRITABLE BOWEL SYNDROME 1346 0.0627
39 RETINITIS 108 0.0625
40 BLOOD PRESSURE SYSTOLIC ABNORMAL 153 0.0618
41 PERICARDITIS 1020 0.0606
42 PORPHYRIA ACUTE 87 0.0606
43 SYNOVITIS 1072 0.0594
44 GRANULOMATOSIS WITH POLYANGIITIS 71 0.0588
45 CHRONIC SINUSITIS 209 0.0556
46 PERIPHERAL VENOUS DISEASE 227 0.0555
47 MIXED LIVER INJURY 167 0.0554
48 PNEUMOCYSTIS JIROVECI PNEUMONIA 123 0.0552
49 AGRANULOCYTOSIS 1015 0.0546
50 CONJUNCTIVITIS ALLERGIC 76 0.0513
51 GLOSSODYNIA 1110 0.0495
52 PARAINFLUENZAE VIRUS INFECTION 75 0.0492
53 ASPERGILLOSIS 64 0.0490
54 LIP DRY 442 0.0486
55 RASH MACULO-PAPULAR 1067 0.0479
56 BICYTOPENIA 91 0.0464
57 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 94 0.0461
58 SCLERITIS 73 0.0455
59 IMPAIRED HEALING 1486 0.0452
60 MATERNAL EXPOSURE TIMING UNSPECIFIED 169 0.0449
61 KIDNEY TRANSPLANT REJECTION 213 0.0443
62 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1137 0.0441
63 RASH MORBILLIFORM 122 0.0440
64 RENAL TUBULAR DISORDER 123 0.0437
65 JOINT RANGE OF MOTION DECREASED 586 0.0436
66 HEPATIC CYTOLYSIS 555 0.0435
67 TOXIC SKIN ERUPTION 436 0.0432
68 RESPIRATORY SYMPTOM 122 0.0429
69 HISTIOCYTOSIS HAEMATOPHAGIC 127 0.0427
70 HEPATOCELLULAR INJURY 600 0.0423
71 CYTOLYTIC HEPATITIS 140 0.0421
72 DERMATITIS EXFOLIATIVE GENERALISED 146 0.0419
73 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 137 0.0414
74 WOUND 1159 0.0414
75 FORCED EXPIRATORY VOLUME DECREASED 114 0.0402
76 RENAL TUBULAR ACIDOSIS 86 0.0394
77 CHOLESTASIS 743 0.0387
78 NORMOCHROMIC NORMOCYTIC ANAEMIA 114 0.0379
79 NOCARDIOSIS 97 0.0379
80 LIVER TRANSPLANT REJECTION 68 0.0378
81 CYTOMEGALOVIRUS TEST POSITIVE 67 0.0376
82 COMPLICATIONS OF TRANSPLANTED KIDNEY 85 0.0374
83 GRAFT VERSUS HOST DISEASE 268 0.0372
84 RHINOVIRUS INFECTION 145 0.0372
85 WOUND INFECTION 404 0.0369
86 CREPITATIONS 109 0.0366
87 ANAEMIA MACROCYTIC 78 0.0365
88 TRANSPLANT REJECTION 290 0.0362
89 GRAFT VERSUS HOST DISEASE IN SKIN 79 0.0358
90 BURSITIS 428 0.0352
91 CYTOKINE RELEASE SYNDROME 704 0.0351
92 PLEURITIC PAIN 96 0.0347
93 BREAST CANCER STAGE III 225 0.0347
94 AUTOIMMUNE DISORDER 338 0.0346
95 PNEUMONIA CYTOMEGALOVIRAL 67 0.0345
96 CYTOMEGALOVIRUS INFECTION 569 0.0342
97 HYPERCHOLESTEROLAEMIA 329 0.0340
98 PULMONARY ALVEOLAR HAEMORRHAGE 189 0.0337
99 BLOOD HIV RNA INCREASED 61 0.0336
100 CHOLESTATIC LIVER INJURY 74 0.0332
101 BRONCHOPULMONARY ASPERGILLOSIS 257 0.0331
102 BONE EROSION 117 0.0331
103 LOWER RESPIRATORY TRACT INFECTION 1493 0.0328
104 MACULAR DEGENERATION 391 0.0327
105 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 106 0.0326
106 GRIP STRENGTH DECREASED 287 0.0326
107 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 84 0.0325
108 LYMPHOPENIA 458 0.0323
109 CYTOMEGALOVIRUS VIRAEMIA 144 0.0323
110 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 176 0.0323
111 SYSTEMIC LUPUS ERYTHEMATOSUS 1145 0.0322
112 HYPERKALAEMIA 1126 0.0321
113 EOSINOPHILIA 561 0.0320
114 ESCHERICHIA BACTERAEMIA 75 0.0319
115 APLASTIC ANAEMIA 166 0.0318
116 CUSHINGOID 101 0.0314
117 TOXIC EPIDERMAL NECROLYSIS 471 0.0310
118 ESCHERICHIA SEPSIS 89 0.0307
119 PANCYTOPENIA 1685 0.0301
120 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 70 0.0301
121 PUSTULAR PSORIASIS 103 0.0300
122 PNEUMOCYSTIS JIROVECII PNEUMONIA 297 0.0295
123 PULMONARY FIBROSIS 566 0.0295
124 PSEUDOMONAS INFECTION 253 0.0295
125 FEBRILE NEUTROPENIA 1954 0.0294
126 STOMATITIS 1786 0.0294
127 ORAL CANDIDIASIS 387 0.0294
128 BK VIRUS INFECTION 99 0.0293
129 STEVENS-JOHNSON SYNDROME 623 0.0280
130 ESCHERICHIA URINARY TRACT INFECTION 119 0.0280
131 HEPATITIS CHOLESTATIC 168 0.0279
132 HYPERTRIGLYCERIDAEMIA 163 0.0278
133 PNEUMONIA FUNGAL 109 0.0276
134 BLISTER 1535 0.0273
135 APLASIA PURE RED CELL 94 0.0273
136 FIBROMYALGIA 661 0.0272
137 THROMBOTIC MICROANGIOPATHY 264 0.0271
138 HEPATITIS FULMINANT 80 0.0269
139 CHRONIC GRAFT VERSUS HOST DISEASE 96 0.0266
140 DERMATITIS EXFOLIATIVE 133 0.0266
141 RASH VESICULAR 128 0.0264
142 CONTRAINDICATED PRODUCT ADMINISTERED 799 0.0264
143 BLOOD CULTURE POSITIVE 79 0.0264
144 RALES 153 0.0263
145 SCIATICA 420 0.0263
146 NEPHROGENIC ANAEMIA 122 0.0263
147 NEUROLOGICAL SYMPTOM 150 0.0262
148 SERUM SICKNESS 73 0.0262
149 ENTEROCOCCAL INFECTION 126 0.0260
150 CLOSTRIDIUM DIFFICILE COLITIS 275 0.0259
151 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 99 0.0259
152 HYPERLACTACIDAEMIA 69 0.0257
153 RENAL TUBULAR NECROSIS 252 0.0257
154 BACTERIAL SEPSIS 82 0.0252
155 HYPERPARATHYROIDISM SECONDARY 63 0.0251
156 INFUSION RELATED REACTION 1652 0.0249
157 STAPHYLOCOCCAL SEPSIS 123 0.0249
158 ECONOMIC PROBLEM 374 0.0247
159 TENOSYNOVITIS 68 0.0246
160 OESOPHAGEAL CANDIDIASIS 98 0.0246
161 THERAPEUTIC PRODUCT EFFECT DECREASED 1096 0.0244
162 TUMOUR LYSIS SYNDROME 214 0.0243
163 LIVE BIRTH 202 0.0241
164 ATELECTASIS 233 0.0241
165 CHRONIC LYMPHOCYTIC LEUKAEMIA 113 0.0238
166 HAEMOLYTIC ANAEMIA 213 0.0238
167 RHEUMATOID NODULE 65 0.0236
168 DRUG TOLERANCE DECREASED 66 0.0235
169 RENAL FAILURE ACUTE 995 0.0234
170 HYPERURICAEMIA 96 0.0233
171 WALKING AID USER 154 0.0233
172 ONYCHOMADESIS 98 0.0233
173 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 138 0.0233
174 HYPERTHERMIA 177 0.0232
175 LUNG CONSOLIDATION 64 0.0229
176 MYOSITIS 205 0.0228
177 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 113 0.0227
178 LUNG DISORDER 1104 0.0225
179 LIVER INJURY 550 0.0224
180 PURPURA 197 0.0222
181 HYPOGAMMAGLOBULINAEMIA 146 0.0222
182 KLEBSIELLA INFECTION 111 0.0219
183 NIGHT SWEATS 705 0.0219
184 SINUSITIS 2236 0.0218
185 VASCULITIS 254 0.0218
186 ADENOVIRUS INFECTION 63 0.0217
187 MENINGITIS ASEPTIC 97 0.0216
188 RENAL TRANSPLANT 78 0.0216
189 CYSTITIS HAEMORRHAGIC 87 0.0216
190 SQUAMOUS CELL CARCINOMA OF SKIN 130 0.0215
191 ARTHROPATHY 1196 0.0215
192 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 167 0.0215
193 THROMBOPHLEBITIS SUPERFICIAL 65 0.0214
194 THROMBOCYTOPENIA 2391 0.0214
195 ILL-DEFINED DISORDER 1297 0.0213
196 BONE MARROW FAILURE 432 0.0212
197 EAR PAIN 412 0.0212
198 LOWER LIMB FRACTURE 405 0.0211
199 SEPTIC SHOCK 913 0.0210
200 ARTERIOSCLEROSIS CORONARY ARTERY 139 0.0210
201 HEPATIC ENZYME INCREASED 1430 0.0210
202 HYPERBILIRUBINAEMIA 217 0.0209
203 STAPHYLOCOCCAL BACTERAEMIA 91 0.0209
204 ANTINUCLEAR ANTIBODY POSITIVE 68 0.0209
205 BACTERAEMIA 248 0.0209
206 ONYCHOMYCOSIS 91 0.0207
207 BREAST CANCER STAGE II 169 0.0203
208 LEUKOPENIA 1012 0.0202
209 LUNG INFILTRATION 178 0.0201
210 OBESITY 320 0.0201
211 TYPE 2 DIABETES MELLITUS 671 0.0199
212 ASPERGILLUS INFECTION 130 0.0198
213 NEUTROPENIA 2687 0.0197
214 CANDIDIASIS 79 0.0197
215 MUSCLE SPASTICITY 241 0.0196
216 SERUM FERRITIN INCREASED 103 0.0195
217 MULTIPLE MYELOMA 91 0.0195
218 HEPATITIS ACUTE 126 0.0194
219 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 145 0.0193
220 FULL BLOOD COUNT ABNORMAL 204 0.0193
221 ACUTE PULMONARY OEDEMA 108 0.0192
222 WOUND DEHISCENCE 65 0.0192
223 PYELONEPHRITIS 166 0.0191
224 LIVER TRANSPLANT 69 0.0190
225 ACUTE KIDNEY INJURY 2902 0.0189
226 DIFFUSE LARGE B-CELL LYMPHOMA 146 0.0189
227 BODY TEMPERATURE INCREASED 386 0.0189
228 GASTROINTESTINAL DISORDER 1690 0.0188
229 CYSTIC FIBROSIS 104 0.0188
230 PLASMA CELL MYELOMA RECURRENT 61 0.0188
231 POTENTIATING DRUG INTERACTION 63 0.0188
232 HYPOALBUMINAEMIA 144 0.0185
233 SYNOVIAL CYST 85 0.0184
234 PYREXIA 6367 0.0184
235 BONE LESION 66 0.0183
236 INFECTION 2635 0.0182
237 VAGINAL DISCHARGE 184 0.0182
238 END STAGE RENAL DISEASE 331 0.0181
239 HYPOVOLAEMIA 106 0.0181
240 HYPOXIA 636 0.0180
241 SWELLING 1688 0.0180
242 HEPATITIS 458 0.0179
243 CYTOMEGALOVIRUS INFECTION REACTIVATION 79 0.0179
244 DISCOMFORT 1089 0.0178
245 VASCULAR DEVICE INFECTION 80 0.0176
246 ACUTE RESPIRATORY DISTRESS SYNDROME 310 0.0175
247 LIPASE INCREASED 134 0.0175
248 BLOOD LACTATE DEHYDROGENASE INCREASED 277 0.0175
249 DERMATITIS BULLOUS 126 0.0174
250 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 143 0.0173
251 PERIPHERAL SENSORY NEUROPATHY 101 0.0173
252 BLOOD LACTIC ACID INCREASED 91 0.0173
253 JOINT EFFUSION 119 0.0172
254 WHEEZING 1015 0.0171
255 OBSTRUCTIVE AIRWAYS DISORDER 190 0.0171
256 FLANK PAIN 160 0.0171
257 HYPOPHOSPHATAEMIA 126 0.0170
258 ANHEDONIA 448 0.0170
259 HEPATOMEGALY 167 0.0170
260 LIVER DISORDER 748 0.0169
261 NODULE 220 0.0168
262 ACUTE GRAFT VERSUS HOST DISEASE 77 0.0168
263 COVID-19 PNEUMONIA 198 0.0168
264 CYTOPENIA 205 0.0167
265 BLOOD CREATININE INCREASED 1089 0.0167
266 EXOSTOSIS 152 0.0166
267 BRONCHIECTASIS 112 0.0166
268 BLOOD PRESSURE SYSTOLIC INCREASED 324 0.0166
269 MUCOSAL INFLAMMATION 432 0.0165
270 PHLEBITIS 84 0.0164
271 RESPIRATORY DISORDER 487 0.0163
272 ARTHRITIS INFECTIVE 75 0.0162
273 TENDERNESS 167 0.0160
274 OEDEMA 869 0.0160
275 FACE OEDEMA 270 0.0160
276 ORTHOSTATIC HYPOTENSION 278 0.0159
277 ENCEPHALOPATHY 390 0.0159
278 IMMUNOSUPPRESSION 140 0.0159
279 JOINT SWELLING 1914 0.0158
280 GAMMA-GLUTAMYLTRANSFERASE INCREASED 351 0.0158
281 PETECHIAE 165 0.0158
282 PNEUMONIA BACTERIAL 145 0.0158
283 GAIT INABILITY 525 0.0157
284 FINGER DEFORMITY 76 0.0157
285 ESCHERICHIA INFECTION 129 0.0157
286 C-REACTIVE PROTEIN INCREASED 570 0.0157
287 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 149 0.0156
288 FAILURE TO THRIVE 81 0.0156
289 ORGANISING PNEUMONIA 77 0.0155
290 EPSTEIN-BARR VIRUS INFECTION 97 0.0155
291 CONTUSION 1477 0.0153
292 PULMONARY FUNCTION TEST DECREASED 67 0.0153
293 MALNUTRITION 171 0.0153
294 PLASMA CELL MYELOMA 596 0.0153
295 BLOOD ALKALINE PHOSPHATASE INCREASED 379 0.0152
296 STAPHYLOCOCCAL INFECTION 499 0.0151
297 BACTERIAL INFECTION 282 0.0151
298 TUBULOINTERSTITIAL NEPHRITIS 283 0.0151
299 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 155 0.0151
300 OSTEOPENIA 227 0.0149
301 BLOOD UREA INCREASED 250 0.0149
302 MULTI-ORGAN FAILURE 258 0.0149
303 LYMPHOCYTE COUNT DECREASED 263 0.0149
304 PANCREATITIS ACUTE 334 0.0148
305 HIP ARTHROPLASTY 226 0.0147
306 BLOOD ALBUMIN DECREASED 117 0.0147
307 EAR INFECTION 392 0.0147
308 HYPONATRAEMIA 828 0.0147
309 BLOOD CREATINE INCREASED 65 0.0147
310 NEUTROPHIL COUNT DECREASED 598 0.0147
311 INJURY 1028 0.0146
312 ECCHYMOSIS 100 0.0146
313 PARAESTHESIA ORAL 210 0.0145
314 INTERSTITIAL LUNG DISEASE 704 0.0145
315 HERPES SIMPLEX 94 0.0144
316 CONFUSIONAL STATE 2334 0.0144
317 HEPATITIS B 87 0.0144
318 NAIL DISORDER 126 0.0144
319 PREGNANCY 288 0.0144
320 PRESCRIBED OVERDOSE 278 0.0144
321 TRANSAMINASES INCREASED 319 0.0143
322 SPLENOMEGALY 168 0.0143
323 BENIGN PROSTATIC HYPERPLASIA 74 0.0143
324 ANAEMIA 2729 0.0143
325 BLOOD PRESSURE DIASTOLIC INCREASED 66 0.0143
326 OSTEOARTHRITIS 604 0.0142
327 ACUTE RESPIRATORY FAILURE 274 0.0142
328 HAEMATOCRIT DECREASED 282 0.0142
329 PRESCRIBED UNDERDOSE 283 0.0142
330 VENOOCCLUSIVE LIVER DISEASE 70 0.0142
331 RENAL FAILURE CHRONIC 109 0.0142
332 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 240 0.0141
333 CHEILITIS 76 0.0140
334 PNEUMONITIS 382 0.0140
335 HYPERCALCAEMIA 173 0.0140
336 CACHEXIA 72 0.0140
337 BLEPHAROSPASM 88 0.0140
338 PSORIATIC ARTHROPATHY 565 0.0139
339 CANDIDA INFECTION 234 0.0138
340 RESPIRATORY RATE INCREASED 123 0.0138
341 DRUG INTOLERANCE 1337 0.0138
342 DEVICE RELATED INFECTION 213 0.0138
343 BLOOD PRESSURE DIASTOLIC DECREASED 102 0.0138
344 SEPSIS 1541 0.0138
345 ARTERIOSCLEROSIS 130 0.0138
346 HYPERVOLAEMIA 68 0.0137
347 LEFT VENTRICULAR DYSFUNCTION 92 0.0137
348 COLITIS 520 0.0137
349 SHOCK HAEMORRHAGIC 111 0.0136
350 SUBCUTANEOUS ABSCESS 65 0.0135
351 SPINAL OSTEOARTHRITIS 119 0.0135
352 ROAD TRAFFIC ACCIDENT 565 0.0135
353 BLOOD BILIRUBIN INCREASED 364 0.0135
354 CHOLECYSTITIS CHRONIC 90 0.0134
355 PATHOLOGICAL FRACTURE 68 0.0134
356 HYPERLIPIDAEMIA 159 0.0133
357 PERIPHERAL SWELLING 2045 0.0133
358 RHINITIS 107 0.0133
359 HYPERNATRAEMIA 66 0.0132
360 SQUAMOUS CELL CARCINOMA 124 0.0132
361 SINUS TACHYCARDIA 187 0.0132
362 PATHOGEN RESISTANCE 120 0.0132
363 ENCEPHALITIS 91 0.0131
364 HAEMATURIA 449 0.0131
365 CONJUNCTIVITIS 243 0.0131
366 RENAL FAILURE 1736 0.0131
367 SLEEP DISORDER 921 0.0130
368 RESPIRATORY DISTRESS 359 0.0130
369 CHRONIC KIDNEY DISEASE 985 0.0130
370 LUNG INFECTION 201 0.0129
371 DELIRIUM 449 0.0129
372 ODYNOPHAGIA 77 0.0129
373 ASPARTATE AMINOTRANSFERASE INCREASED 685 0.0129
374 INFUSION SITE SWELLING 81 0.0129
375 LUPUS-LIKE SYNDROME 116 0.0128
376 ATRIAL FLUTTER 102 0.0128
377 STREPTOCOCCAL INFECTION 71 0.0127
378 TACHYPNOEA 173 0.0127
379 DECREASED ACTIVITY 137 0.0127
380 COMPRESSION FRACTURE 68 0.0127
381 ALANINE AMINOTRANSFERASE INCREASED 777 0.0126
382 PHARYNGITIS 156 0.0126
383 HYDRONEPHROSIS 94 0.0125
384 FOOT DEFORMITY 139 0.0125
385 FREQUENT BOWEL MOVEMENTS 338 0.0125
386 BLOOD CHOLESTEROL INCREASED 583 0.0125
387 JOINT DISLOCATION 132 0.0125
388 GENERALISED ERYTHEMA 71 0.0125
389 PNEUMOTHORAX 198 0.0125
390 MUSCULOSKELETAL PAIN 653 0.0125
391 HAEMODIALYSIS 104 0.0124
392 MENTAL STATUS CHANGES 342 0.0123
393 PULMONARY TOXICITY 87 0.0123
394 PLATELET COUNT DECREASED 1307 0.0123
395 FULL BLOOD COUNT DECREASED 247 0.0122
396 GENERAL PHYSICAL HEALTH DETERIORATION 1417 0.0122
397 INFLAMMATION 631 0.0122
398 HYPERTRANSAMINASAEMIA 85 0.0122
399 PROTHROMBIN TIME PROLONGED 73 0.0122
400 GASTROENTERITIS 178 0.0122
401 ELECTROLYTE IMBALANCE 141 0.0121
402 URINE OUTPUT DECREASED 106 0.0121
403 HYPERSENSITIVITY 2246 0.0121
404 ACIDOSIS 92 0.0120
405 CELLULITIS 604 0.0120
406 RESPIRATORY FAILURE 874 0.0120
407 METABOLIC ACIDOSIS 382 0.0119
408 RESPIRATORY SYNCYTIAL VIRUS INFECTION 104 0.0119
409 GENERAL SYMPTOM 89 0.0119
410 JAUNDICE 318 0.0118
411 NEPHROTIC SYNDROME 81 0.0118
412 HAEMOPTYSIS 329 0.0118
413 CLOSTRIDIUM DIFFICILE INFECTION 257 0.0118
414 MYELODYSPLASTIC SYNDROME 170 0.0117
415 UPPER RESPIRATORY TRACT INFECTION 542 0.0117
416 WHITE BLOOD CELL COUNT DECREASED 1270 0.0117
417 BODY TEMPERATURE DECREASED 115 0.0117
418 MENINGITIS 78 0.0117
419 NEPHROPATHY 109 0.0117
420 RHEUMATOID ARTHRITIS 1322 0.0116
421 CHOLANGITIS 72 0.0116
422 OSTEOPOROSIS 473 0.0115
423 LEUKOCYTOSIS 208 0.0115
424 PNEUMONIA ASPIRATION 286 0.0114
425 DYSPNOEA EXERTIONAL 431 0.0114
426 OXYGEN SATURATION DECREASED 643 0.0114
427 HYPERKERATOSIS 63 0.0114
428 PROTEINURIA 217 0.0114
429 PLEURAL EFFUSION 692 0.0114
430 RED BLOOD CELL COUNT DECREASED 324 0.0113
431 BACK DISORDER 184 0.0113
432 DISSEMINATED INTRAVASCULAR COAGULATION 159 0.0113
433 LYMPHADENOPATHY 399 0.0113
434 INTERVERTEBRAL DISC DEGENERATION 104 0.0112
435 MYOCLONUS 134 0.0112
436 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 192 0.0112
437 CYSTITIS 356 0.0112
438 BLOOD POTASSIUM INCREASED 181 0.0111
439 NECROSIS 62 0.0111
440 PRODUCTIVE COUGH 530 0.0111
441 HYPOKALAEMIA 511 0.0111
442 MULTIPLE ORGAN DYSFUNCTION SYNDROME 311 0.0110
443 URINARY TRACT INFECTION 1864 0.0109
444 FUNGAL INFECTION 364 0.0109
445 NEUROPATHY PERIPHERAL 1038 0.0109
446 INFUSION SITE ERYTHEMA 92 0.0109
447 BLOOD URIC ACID INCREASED 63 0.0109
448 ACUTE MYELOID LEUKAEMIA 170 0.0109
449 PNEUMONIA 3524 0.0109
450 PULMONARY HAEMORRHAGE 85 0.0109
451 COAGULOPATHY 181 0.0109
452 UROSEPSIS 100 0.0108
453 LIVER FUNCTION TEST INCREASED 232 0.0108
454 ACUTE CORONARY SYNDROME 89 0.0107
455 MUSCULOSKELETAL CHEST PAIN 166 0.0107
456 RESPIRATORY TRACT INFECTION 279 0.0107
457 NASOPHARYNGITIS 1973 0.0107
458 RENAL CYST 85 0.0107
459 VIRAL INFECTION 356 0.0107
460 HAEMOGLOBIN DECREASED 1097 0.0107
461 RECTAL HAEMORRHAGE 458 0.0106
462 INTENTIONAL PRODUCT USE ISSUE 933 0.0106
463 HEPATIC STEATOSIS 198 0.0106
464 RED BLOOD CELL SEDIMENTATION RATE INCREASED 117 0.0106
465 BLOOD MAGNESIUM DECREASED 91 0.0105
466 DEEP VEIN THROMBOSIS 684 0.0105
467 TOOTH ABSCESS 107 0.0105
468 BONE DENSITY DECREASED 329 0.0105
469 DRUG-INDUCED LIVER INJURY 329 0.0105
470 HYPOPHAGIA 268 0.0105
471 ANOREXIA 135 0.0105
472 NEUTROPHIL COUNT INCREASED 107 0.0104
473 RASH 4554 0.0104
474 DRUG ERUPTION 185 0.0104
475 NEPHROPATHY TOXIC 117 0.0104
476 OEDEMA PERIPHERAL 1270 0.0104
477 PHOTOSENSITIVITY REACTION 172 0.0104
478 BACK INJURY 113 0.0104
479 HEPATIC CIRRHOSIS 195 0.0104
480 UPPER-AIRWAY COUGH SYNDROME 85 0.0103
481 DECUBITUS ULCER 84 0.0103
482 CARDIAC MURMUR 89 0.0103
483 SPINAL COMPRESSION FRACTURE 85 0.0103
484 KNEE ARTHROPLASTY 216 0.0102
485 RENAL IMPAIRMENT 856 0.0102
486 HYPOMAGNESAEMIA 141 0.0101
487 EMBOLISM 84 0.0101
488 PROCTALGIA 65 0.0101
489 GENERALISED OEDEMA 125 0.0101
490 ORAL DISORDER 74 0.0101
491 BLOOD SODIUM DECREASED 190 0.0101
492 ERYTHEMA MULTIFORME 94 0.0101
493 MITRAL VALVE INCOMPETENCE 114 0.0101
494 OESOPHAGITIS 110 0.0101
495 INTERNATIONAL NORMALISED RATIO INCREASED 287 0.0101
496 DRUG LEVEL INCREASED 166 0.0100
497 ANURIA 86 0.0100
498 HEPATIC FAILURE 301 0.0100
499 SEASONAL ALLERGY 141 0.0100
500 RASH GENERALISED 257 0.0099
501 ULCER 157 0.0099
502 ENTERITIS 63 0.0098
503 VITAMIN D DEFICIENCY 96 0.0098
504 ASCITES 289 0.0098
505 MUSCULOSKELETAL STIFFNESS 859 0.0098
506 PULMONARY MASS 146 0.0098
507 SKIN LESION 267 0.0097
508 PERICARDIAL EFFUSION 225 0.0097
509 URTICARIA 1629 0.0097
510 SKIN INFECTION 109 0.0097
511 MOBILITY DECREASED 696 0.0097
512 GOUT 173 0.0096
513 INFUSION SITE PAIN 124 0.0096
514 GASTROOESOPHAGEAL REFLUX DISEASE 774 0.0096
515 OSTEOMYELITIS 174 0.0096
516 BRONCHITIS 711 0.0096
517 CARDIOMEGALY 118 0.0096
518 PULMONARY EMBOLISM 911 0.0096
519 HAEMOLYSIS 74 0.0096
520 DRUG RESISTANCE 245 0.0095
521 PHOTOPHOBIA 179 0.0095
522 ABDOMINAL DISCOMFORT 1593 0.0095
523 DRY MOUTH 769 0.0095
524 NEUROTOXICITY 166 0.0095
525 BLOOD PRESSURE FLUCTUATION 227 0.0094
526 ARTHROPOD BITE 70 0.0094
527 PANCREATITIS 499 0.0094
528 WEIGHT INCREASED 2110 0.0094
529 FEEDING DISORDER 191 0.0094
530 EJECTION FRACTION DECREASED 146 0.0094
531 HYPERGLYCAEMIA 342 0.0094
532 DEHYDRATION 1251 0.0094
533 HYPOCALCAEMIA 177 0.0093
534 THERAPY NON-RESPONDER 420 0.0093
535 RASH PUSTULAR 68 0.0093
536 WHITE BLOOD CELL COUNT INCREASED 358 0.0093
537 SKIN ULCER 241 0.0093
538 ADRENAL INSUFFICIENCY 113 0.0093
539 ULCER HAEMORRHAGE 63 0.0093
540 WEIGHT FLUCTUATION 97 0.0093
541 LARGE INTESTINE PERFORATION 64 0.0092
542 DEFORMITY 86 0.0092
543 MATERNAL EXPOSURE DURING PREGNANCY 816 0.0091
544 HIATUS HERNIA 118 0.0091
545 NEUTROPENIC SEPSIS 65 0.0091
546 DYSURIA 332 0.0090
547 FLUID OVERLOAD 131 0.0090
548 DYSPEPSIA 885 0.0090
549 ABDOMINAL PAIN 2092 0.0090
550 LABORATORY TEST ABNORMAL 265 0.0090
551 BASAL CELL CARCINOMA 140 0.0090
552 TRANSFUSION 94 0.0090
553 COELIAC DISEASE 88 0.0090
554 RASH PRURITIC 486 0.0090
555 HEART RATE DECREASED 314 0.0089
556 APHTHOUS ULCER 69 0.0089
557 SMALL INTESTINAL OBSTRUCTION 109 0.0088
558 ATRIAL FIBRILLATION 862 0.0088
559 SWOLLEN TONGUE 276 0.0088
560 LOCALISED INFECTION 212 0.0088
561 EMPHYSEMA 88 0.0087
562 CHILLS 1022 0.0087
563 BLOOD CALCIUM DECREASED 98 0.0087
564 BLOOD COUNT ABNORMAL 132 0.0087
565 LIVER FUNCTION TEST ABNORMAL 253 0.0087
566 TRICUSPID VALVE INCOMPETENCE 69 0.0087
567 HEPATIC ENCEPHALOPATHY 81 0.0087
568 DIALYSIS 123 0.0087
569 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 416 0.0087
570 SLEEP APNOEA SYNDROME 165 0.0086
571 TASTE DISORDER 175 0.0086
572 HOSPICE CARE 85 0.0086
573 TACHYCARDIA 764 0.0086
574 ATAXIA 102 0.0086
575 FURUNCLE 68 0.0086
576 ISCHAEMIC STROKE 153 0.0086
577 COLITIS ULCERATIVE 383 0.0086
578 PULMONARY HYPERTENSION 177 0.0085
579 COMA 404 0.0085
580 NEURALGIA 206 0.0085
581 DRUG INTERACTION 1343 0.0085
582 SUPRAVENTRICULAR TACHYCARDIA 81 0.0085
583 DISABILITY 166 0.0084
584 IMMUNODEFICIENCY 125 0.0084
585 HAEMATOMA 217 0.0084
586 DECREASED APPETITE 1945 0.0084
587 TOOTH FRACTURE 92 0.0083
588 RASH ERYTHEMATOUS 398 0.0083
589 STATUS EPILEPTICUS 94 0.0083
590 GASTRITIS 219 0.0083
591 MULTIPLE ALLERGIES 65 0.0083
592 GALLBLADDER DISORDER 148 0.0083
593 ILEUS 103 0.0083
594 VOMITING 3855 0.0082
595 TOOTH INFECTION 108 0.0082
596 HYPERTENSION 1733 0.0082
597 DISEASE PROGRESSION 966 0.0082
598 HYPOTENSION 1637 0.0082
599 EOSINOPHIL COUNT INCREASED 68 0.0082
600 DRUG TOXICITY 111 0.0081
601 ORAL PAIN 182 0.0081
602 SPUTUM DISCOLOURED 77 0.0081
603 PROCEDURAL PAIN 225 0.0081
604 MYOPATHY 70 0.0081
605 TOOTH LOSS 168 0.0081
606 WEIGHT DECREASED 2258 0.0081
607 RIB FRACTURE 166 0.0081
608 ANGIOEDEMA 357 0.0081
609 CYST 100 0.0080
610 GLOMERULAR FILTRATION RATE DECREASED 99 0.0080
611 DYSPNOEA 4560 0.0080
612 FLUID RETENTION 409 0.0080
613 CONGENITAL ANOMALY 62 0.0080
614 PRURITUS 3070 0.0080
615 ASTHENIA 3000 0.0080
616 JOINT STIFFNESS 209 0.0080
617 SINUS BRADYCARDIA 77 0.0080
618 MUSCULAR WEAKNESS 903 0.0079
619 KIDNEY INFECTION 155 0.0079
620 VENTRICULAR EXTRASYSTOLES 82 0.0079
621 URINARY RETENTION 263 0.0079
622 PULMONARY OEDEMA 352 0.0079
623 BONE LOSS 118 0.0078
624 HYPOTHYROIDISM 250 0.0078
625 DIARRHOEA 5049 0.0078
626 HEPATOTOXICITY 174 0.0078
627 GASTROENTERITIS VIRAL 141 0.0078
628 HYPOAESTHESIA 1167 0.0078
629 ABSCESS 124 0.0078
630 SWELLING FACE 506 0.0078
631 AMNESIA 505 0.0078
632 TREATMENT FAILURE 641 0.0077
633 OSTEONECROSIS 253 0.0077
634 SKIN HYPERPIGMENTATION 66 0.0077
635 FOOT FRACTURE 145 0.0076
636 DERMATITIS ALLERGIC 96 0.0076
637 QUALITY OF LIFE DECREASED 102 0.0076
638 MYOCARDITIS 87 0.0076
639 EPILEPSY 232 0.0076
640 IRON DEFICIENCY ANAEMIA 70 0.0076
641 LYMPHOMA 117 0.0076
642 HICCUPS 62 0.0075
643 BLOOD URINE PRESENT 143 0.0075
644 CHEST PAIN 1387 0.0075
645 SINUS CONGESTION 101 0.0075
646 CHOLECYSTITIS 89 0.0075
647 SECOND PRIMARY MALIGNANCY 62 0.0074
648 DENTAL CARIES 82 0.0074
649 MOUTH ULCERATION 156 0.0074
650 SHOCK 168 0.0073
651 ASTHMA 823 0.0073
652 HAEMORRHOIDS 142 0.0073
653 HERPES ZOSTER 416 0.0072
654 IMMUNE SYSTEM DISORDER 95 0.0072
655 SCAR 123 0.0072
656 GASTROINTESTINAL PAIN 79 0.0072
657 BLOOD POTASSIUM DECREASED 215 0.0071
658 CHOLELITHIASIS 234 0.0071
659 PLATELET COUNT INCREASED 93 0.0071
660 SUDDEN DEATH 75 0.0071
661 FATIGUE 5514 0.0071
662 INCREASED TENDENCY TO BRUISE 65 0.0071
663 CARDIOMYOPATHY 104 0.0070
664 ABDOMINAL PAIN UPPER 1445 0.0070
665 HAEMATOCHEZIA 387 0.0070
666 COUGH 1959 0.0070
667 NEPHROLITHIASIS 320 0.0070
668 ARTHRALGIA 2900 0.0070
669 CONSTIPATION 1520 0.0070
670 CARDIOGENIC SHOCK 100 0.0070
671 SINUS DISORDER 138 0.0070
672 THROMBOSIS 560 0.0070
673 CONDITION AGGRAVATED 2116 0.0070
674 MULTIPLE FRACTURES 114 0.0069
675 ALOPECIA 1362 0.0069
676 CARDIAC FAILURE 552 0.0069
677 BRONCHOSPASM 98 0.0069
678 POOR VENOUS ACCESS 71 0.0069
679 BONE DISORDER 125 0.0069
680 PULMONARY CONGESTION 90 0.0068
681 PAIN 4167 0.0068
682 NO THERAPEUTIC RESPONSE 82 0.0067
683 OFF LABEL USE 5874 0.0067
684 PULMONARY THROMBOSIS 73 0.0067
685 BLOOD TRIGLYCERIDES INCREASED 118 0.0067
686 RASH PAPULAR 149 0.0066
687 BACK PAIN 1543 0.0066
688 ANXIETY 1872 0.0066
689 DYSPHONIA 384 0.0066
690 LACTIC ACIDOSIS 212 0.0065
691 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 465 0.0065
692 HYPOTHERMIA 66 0.0065
693 DIABETES MELLITUS INADEQUATE CONTROL 115 0.0065
694 ASPIRATION 71 0.0065
695 INFLUENZA 716 0.0064
696 JOINT INJURY 137 0.0064
697 EPISTAXIS 477 0.0064
698 RENAL DISORDER 297 0.0064
699 VENTRICULAR TACHYCARDIA 105 0.0064
700 POLYNEUROPATHY 76 0.0063
701 BLADDER DISORDER 63 0.0063
702 ADVERSE REACTION 84 0.0063
703 ERYTHEMA 1302 0.0063
704 MYOCARDIAL ISCHAEMIA 72 0.0063
705 INSOMNIA 1685 0.0063
706 DYSPHAGIA 600 0.0063
707 NECK PAIN 352 0.0063
708 FEELING JITTERY 120 0.0063
709 RESPIRATORY TRACT CONGESTION 100 0.0063
710 NAUSEA 4962 0.0063
711 ACUTE HEPATIC FAILURE 85 0.0062
712 HEPATIC FUNCTION ABNORMAL 232 0.0062
713 HYPOGLYCAEMIA 301 0.0062
714 BRAIN OEDEMA 78 0.0062
715 PULMONARY ARTERIAL HYPERTENSION 89 0.0061
716 SUBDURAL HAEMATOMA 87 0.0061
717 RHABDOMYOLYSIS 253 0.0061
718 CARDIO-RESPIRATORY ARREST 253 0.0060
719 CONVULSION 344 0.0060
720 RASH MACULAR 210 0.0060
721 ROTATOR CUFF SYNDROME 77 0.0060
722 RESTLESS LEGS SYNDROME 109 0.0060
723 DEAFNESS 156 0.0060
724 RENAL INJURY 177 0.0060
725 DIVERTICULITIS 165 0.0059
726 APHASIA 179 0.0059
727 DERMATITIS 124 0.0059
728 TENDON RUPTURE 73 0.0059
729 MEDICATION ERROR 328 0.0059
730 ORAL HERPES 115 0.0059
731 INSURANCE ISSUE 90 0.0059
732 MIGRAINE 561 0.0059
733 NASAL CONGESTION 345 0.0059
734 MUSCLE SPASMS 1073 0.0058
735 BONE PAIN 342 0.0058
736 PHARYNGITIS STREPTOCOCCAL 63 0.0058
737 EMOTIONAL DISTRESS 701 0.0058
738 MELAENA 127 0.0058
739 OROPHARYNGEAL PAIN 533 0.0058
740 NEOPLASM 66 0.0057
741 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 315 0.0057
742 HEART RATE INCREASED 568 0.0057
743 EATING DISORDER 122 0.0057
744 HEMIPARESIS 97 0.0057
745 IMPAIRED GASTRIC EMPTYING 78 0.0057
746 COVID-19 1003 0.0057
747 CARPAL TUNNEL SYNDROME 80 0.0057
748 PALLOR 155 0.0057
749 CHOLECYSTECTOMY 65 0.0057
750 NOCTURIA 69 0.0057
751 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 293 0.0056
752 DERMATITIS CONTACT 64 0.0056
753 TREMOR 930 0.0056
754 PRESYNCOPE 136 0.0056
755 UPPER GASTROINTESTINAL HAEMORRHAGE 94 0.0056
756 NERVE INJURY 62 0.0056
757 PARAESTHESIA 876 0.0056
758 ANKLE FRACTURE 86 0.0056
759 DEPRESSION 1262 0.0055
760 HALLUCINATION, VISUAL 117 0.0055
761 ELECTROCARDIOGRAM QT PROLONGED 199 0.0055
762 AGEUSIA 137 0.0055
763 BLOOD CREATINE PHOSPHOKINASE INCREASED 158 0.0055
764 URINARY INCONTINENCE 162 0.0055
765 HEADACHE 3418 0.0054
766 INTERVERTEBRAL DISC PROTRUSION 119 0.0054
767 SKIN DISCOLOURATION 250 0.0054
768 BRADYCARDIA 288 0.0054
769 ANAPHYLACTIC REACTION 300 0.0054
770 DYSARTHRIA 203 0.0054
771 ABDOMINAL DISTENSION 561 0.0054
772 GASTROINTESTINAL HAEMORRHAGE 448 0.0054
773 PAIN IN EXTREMITY 1577 0.0053
774 BLOOD TEST ABNORMAL 75 0.0053
775 PRODUCT USE IN UNAPPROVED INDICATION 1321 0.0053
776 DISORIENTATION 211 0.0053
777 GASTRIC ULCER 101 0.0053
778 CHROMATURIA 119 0.0053
779 LIMB INJURY 143 0.0053
780 MALAISE 2304 0.0052
781 EYELID OEDEMA 61 0.0052
782 CARDIAC ARREST 433 0.0052
783 HEART RATE IRREGULAR 118 0.0052
784 CORONARY ARTERY DISEASE 158 0.0052
785 SKIN EXFOLIATION 440 0.0052
786 SECRETION DISCHARGE 65 0.0052
787 ARTHRITIS 407 0.0052
788 WRIST FRACTURE 62 0.0052
789 NERVOUS SYSTEM DISORDER 161 0.0052
790 POLLAKIURIA 215 0.0052
791 LETHARGY 296 0.0051
792 TOOTH DISORDER 114 0.0051
793 GAIT DISTURBANCE 980 0.0051
794 SKIN CANCER 110 0.0051
795 POST PROCEDURAL COMPLICATION 98 0.0051
796 PAIN IN JAW 144 0.0051
797 MYALGIA 863 0.0051
798 BLOOD PRESSURE DECREASED 336 0.0051
799 IMPAIRED WORK ABILITY 108 0.0050
800 DRY EYE 252 0.0050
801 MASS 70 0.0050
802 MEMORY IMPAIRMENT 687 0.0050
803 SPINAL FRACTURE 100 0.0050
804 CEREBRAL HAEMORRHAGE 178 0.0050
805 RHINORRHOEA 321 0.0050
806 DIABETES MELLITUS 377 0.0049
807 SKIN REACTION 69 0.0049
808 CARDIAC FAILURE CONGESTIVE 390 0.0049
809 ACUTE MYOCARDIAL INFARCTION 143 0.0048
810 GINGIVAL BLEEDING 66 0.0048
811 MUSCULOSKELETAL DISORDER 92 0.0048
812 VERTIGO 293 0.0048
813 DISEASE RECURRENCE 227 0.0048
814 CYANOSIS 75 0.0048
815 SKIN DISORDER 159 0.0048
816 HERNIA 92 0.0048
817 HAEMORRHAGE INTRACRANIAL 71 0.0047
818 PERITONITIS 98 0.0047
819 ARRHYTHMIA 224 0.0047
820 BLOOD PRESSURE INCREASED 723 0.0047
821 SNEEZING 106 0.0047
822 PRODUCT USE ISSUE 886 0.0047
823 FEELING HOT 289 0.0047
824 BLOOD PRESSURE ABNORMAL 93 0.0047
825 ABDOMINAL PAIN LOWER 118 0.0047
826 MIDDLE INSOMNIA 87 0.0047
827 LOCAL SWELLING 81 0.0046
828 ADVERSE DRUG REACTION 417 0.0046
829 TOOTHACHE 84 0.0046
830 SYNCOPE 464 0.0046
831 NEOPLASM PROGRESSION 161 0.0046
832 UPPER LIMB FRACTURE 92 0.0046
833 HALLUCINATION 348 0.0046
834 RETCHING 98 0.0046
835 LIP SWELLING 153 0.0046
836 FALL 1528 0.0046
837 TENDONITIS 70 0.0045
838 INTESTINAL OBSTRUCTION 170 0.0045
839 DIZZINESS 2244 0.0045
840 CATARACT 266 0.0045
841 SOMNOLENCE 893 0.0044
842 GENERALISED TONIC-CLONIC SEIZURE 73 0.0044
843 DIPLOPIA 112 0.0043
844 FEELING COLD 120 0.0043
845 ACTIVITIES OF DAILY LIVING IMPAIRED 85 0.0043
846 EXPOSURE DURING PREGNANCY 266 0.0043
847 LOSS OF CONSCIOUSNESS 547 0.0043
848 HAEMATEMESIS 108 0.0043
849 CHEST DISCOMFORT 435 0.0042
850 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 99 0.0042
851 ALTERED STATE OF CONSCIOUSNESS 92 0.0042
852 HOSPITALISATION 645 0.0042
853 POOR QUALITY SLEEP 89 0.0041
854 HIP FRACTURE 132 0.0041
855 PHARYNGEAL OEDEMA 63 0.0041
856 TREATMENT NONCOMPLIANCE 224 0.0041
857 TRANSIENT ISCHAEMIC ATTACK 138 0.0041
858 SPEECH DISORDER 212 0.0040
859 THERAPY PARTIAL RESPONDER 63 0.0040
860 PRURITUS GENERALISED 87 0.0040
861 ADVERSE EVENT 370 0.0040
862 EYE PAIN 226 0.0040
863 THROAT IRRITATION 179 0.0040
864 DYSSTASIA 116 0.0040
865 FAECES DISCOLOURED 86 0.0040
866 FRACTURE 75 0.0040
867 UNRESPONSIVE TO STIMULI 102 0.0039
868 MUSCULOSKELETAL DISCOMFORT 68 0.0039
869 HEAD INJURY 125 0.0039
870 MALIGNANT NEOPLASM PROGRESSION 402 0.0039
871 TINNITUS 180 0.0039
872 BALANCE DISORDER 338 0.0039
873 OCULAR HYPERAEMIA 185 0.0039
874 SEIZURE 450 0.0039
875 HYPERSOMNIA 111 0.0039
876 AGITATION 284 0.0039
877 INFLUENZA LIKE ILLNESS 317 0.0038
878 COGNITIVE DISORDER 179 0.0038
879 PRODUCT ADMINISTRATION ERROR 77 0.0038
880 FLATULENCE 216 0.0038
881 OSTEONECROSIS OF JAW 94 0.0038
882 UNEVALUABLE EVENT 286 0.0038
883 ECZEMA 197 0.0038
884 DEPRESSED LEVEL OF CONSCIOUSNESS 148 0.0037
885 CEREBRAL INFARCTION 91 0.0037
886 FEMUR FRACTURE 115 0.0037
887 CIRCULATORY COLLAPSE 63 0.0037
888 VISUAL IMPAIRMENT 454 0.0037
889 PALPITATIONS 426 0.0036
890 VISION BLURRED 499 0.0036
891 EYE DISORDER 119 0.0036
892 ANGINA PECTORIS 103 0.0036
893 HAEMORRHAGE 375 0.0036
894 BURNING SENSATION 251 0.0036
895 HYPERHIDROSIS 458 0.0036
896 GLAUCOMA 68 0.0035
897 THROAT TIGHTNESS 95 0.0035
898 LIMB DISCOMFORT 108 0.0035
899 THERAPEUTIC RESPONSE DECREASED 209 0.0034
900 EYE SWELLING 128 0.0034
901 MENTAL DISORDER 149 0.0034
902 VISUAL ACUITY REDUCED 113 0.0034
903 ABASIA 84 0.0034
904 THINKING ABNORMAL 62 0.0033
905 ILLNESS 341 0.0033
906 HOT FLUSH 249 0.0033
907 DRUG EXPOSURE DURING PREGNANCY 112 0.0033
908 DYSKINESIA 133 0.0033
909 DYSGEUSIA 243 0.0033
910 DISTURBANCE IN ATTENTION 175 0.0032
911 CARDIAC DISORDER 301 0.0032
912 MUSCLE TWITCHING 74 0.0032
913 GASTRIC DISORDER 110 0.0032
914 ACCIDENTAL OVERDOSE 116 0.0032
915 MOVEMENT DISORDER 101 0.0031
916 INTENTIONAL DOSE OMISSION 89 0.0031
917 NEOPLASM MALIGNANT 208 0.0031
918 PREMATURE BABY 93 0.0031
919 FEAR 83 0.0031
920 PRODUCT AVAILABILITY ISSUE 70 0.0031
921 RESPIRATORY ARREST 84 0.0030
922 HYPOACUSIS 131 0.0030
923 DIABETIC KETOACIDOSIS 73 0.0030
924 NERVOUSNESS 158 0.0030
925 PRODUCT DOSE OMISSION ISSUE 880 0.0030
926 SURGERY 174 0.0030
927 ANAPHYLACTIC SHOCK 76 0.0029
928 DRUG INEFFECTIVE 3868 0.0029
929 LACRIMATION INCREASED 88 0.0029
930 FLUSHING 296 0.0029
931 BLINDNESS 115 0.0028
932 DEATH 2421 0.0028
933 EMOTIONAL DISORDER 86 0.0028
934 UNDERDOSE 203 0.0028
935 ABNORMAL BEHAVIOUR 110 0.0028
936 PRODUCT DOSE OMISSION 180 0.0028
937 DRY SKIN 368 0.0028
938 FEELING ABNORMAL 651 0.0027
939 FOETAL EXPOSURE DURING PREGNANCY 217 0.0027
940 MENTAL IMPAIRMENT 64 0.0026
941 BLOOD GLUCOSE DECREASED 125 0.0026
942 PANIC ATTACK 94 0.0026
943 THERAPY INTERRUPTED 183 0.0026
944 MYOCARDIAL INFARCTION 430 0.0025
945 BLOOD GLUCOSE INCREASED 463 0.0025
946 EXTRAPYRAMIDAL DISORDER 61 0.0025
947 THERAPY CESSATION 125 0.0024
948 PRODUCT DOSE OMISSION IN ERROR 68 0.0024
949 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 431 0.0024
950 MOOD ALTERED 65 0.0024
951 RESTLESSNESS 87 0.0024
952 ERECTILE DYSFUNCTION 61 0.0024
953 CEREBROVASCULAR ACCIDENT 401 0.0024
954 TARDIVE DYSKINESIA 66 0.0023
955 PSYCHOTIC DISORDER 69 0.0023
956 IRRITABILITY 140 0.0023
957 DEPRESSED MOOD 119 0.0022
958 INJECTION SITE REACTION 154 0.0022
959 CRYING 81 0.0022
960 EYE IRRITATION 128 0.0022
961 THERAPEUTIC RESPONSE UNEXPECTED 97 0.0022
962 ABORTION SPONTANEOUS 86 0.0021
963 PSORIASIS 280 0.0021
964 NIGHTMARE 74 0.0021
965 AGGRESSION 106 0.0021
966 MYELOSUPPRESSION 75 0.0021
967 MOOD SWINGS 65 0.0020
968 TOXICITY TO VARIOUS AGENTS 334 0.0020
969 EYE PRURITUS 66 0.0020
970 OVERDOSE 404 0.0019
971 SUICIDAL IDEATION 170 0.0019
972 LUNG NEOPLASM MALIGNANT 75 0.0018
973 ACNE 138 0.0018
974 MULTIPLE SCLEROSIS 81 0.0017
975 DRUG DOSE OMISSION 267 0.0016
976 VAGINAL HAEMORRHAGE 66 0.0015
977 SUICIDE ATTEMPT 87 0.0014
978 INCORRECT DOSE ADMINISTERED 320 0.0014
979 PROSTATE CANCER 107 0.0013
980 INTENTIONAL PRODUCT MISUSE 112 0.0013
981 MULTIPLE SCLEROSIS RELAPSE 85 0.0012
982 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 86 0.0012
983 PRODUCT QUALITY ISSUE 156 0.0011
984 SKIN BURNING SENSATION 73 0.0010
985 INJECTION SITE SWELLING 77 0.0010
986 NO ADVERSE EVENT 182 0.0010
987 INJECTION SITE ERYTHEMA 121 0.0010
988 DEVICE ISSUE 86 0.0010
989 INJECTION SITE BRUISING 73 0.0009
990 INJECTION SITE PAIN 261 0.0009
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 155 0.0008
992 BREAST CANCER 66 0.0007
993 DRUG DEPENDENCE 77 0.0005